Two Seas Capital Opposes Core Scientific–CoreWeave Merger, Calls Deal Undervalued, Risky For Shareholders
5h ago•
bullish:
0
bearish:
0
Share

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.
5h ago•
bullish:
0
bearish:
0
Share
Securely connect the portfolio you’re using to start.